Moussa Mansour, MD, is the Director of the Cardiac Electrophysiology Laboratory and Director of the Atrial Fibrillation Program at Massachusetts General Hospital.
Dr. Mansour is an active clinical consultant in all aspects of heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, supraventricular tachycardia, bradycardia and other abnormal rhythms. Dr. Mansour performs a large number of catheter ablation procedures and implants pacemakers and defibrillators to treat different arrhythmias.
Dr. Mansour has published extensively in the field of cardiac arrhythmia, specifically the area of Atrial Fibrillation. He is involved in cutting edge research and currently participating in the development of new catheters for the treatment of atrial fibrillation.
ResearchDr. Mansour's area of research is catheter ablation for atrial fibrillation. He is participating in numerous studies with the objective of finding safer and more effective ways to treat this arrhythmia. Some of the tools he is investigating are the cryo-balloon and the LASER balloon for pulmonary vein isolation. Dr Mansour is also involved in NIH-sponsored research aiming at defining the indications for atrial fibrillation ablation and identifying patients groups who will benefit from the procedure and comparing it to pharmacological treatment. Another area of research that Dr Mansour is involved in is stroke prevention for atrial fibrillation using non-pharmacological tools such as the left atrial apendage occlusion device, which may have significant value for patients taking warfarin.
Mansour M, Refaat M, Heist K, Mela T, Cury R, Holmvang G , Ruskin J. Three-Dimensional Anatomy of the Left Atrium by Magnetic Resonance Angiography Implications for Catheter Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 2006;(17):719-723
Mansour M, Reddy V, Singh V, Mela T, Rasche V, Ruskin J. Three-dimensional reconstruction of the coronary sinus using rotational angiography. J Cardiovasc Electrophysiol. 2005 Jun;16(6):675-6.
Mansour M, Holmvang G, Ruskin J. Usefulness of Imaging Techniques in Preparation of Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 2004;15:1107-1108
Mansour M, Ruskin J, Keane D. Efficacy and Safety of Segmental Ostial versus Circumferential Extra-Ostial Pulmonary Vein Isolation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 2004; 15:532-537.
Mass General Heart Center physicians are evaluating a new medical device that shows promise in preventing strokes among patients with atrial fibrillation.
Cryoballoon ablation is a new procedure available at the Massachusetts General Hospital Heart Center that is showing promise as an alternative therapy to treat atrial fibrillation, a type of heart rhythm disorder.
The Mass General Institute for Heart, Vascular, and Stroke Care integrates services to accelerate advances in stroke-related atrial fibrillation research and patient care.
Ed Cleary came to Massachusetts General Hospital in June 2012 to get his AFib treated. He had tried taking a blood thinner to help manage his AFib, but bled too much. Fortunately, he qualified for a new procedure now being used for the first time in New England by Mass General Hospital.
A new clinical trial is now underway at the MGH to investigate whether combining two catheter-based procedures will improve the long-term outcome in the treatment of atrial fibrillation, the most common heart rhythm disorder. The MGH is the first hospital in New England – and only the second in the nation – to pair renal artery sympathetic denervation with pulmonary vein isolation (PVI) for patients with atrial fibrillation and hypertension.
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present their experience and provide a practical guide to clinical decision making for patients with heart failure, pulmonary embolism and cardiogenic stroke.
A new clinical trial is now underway at the Massachusetts General Hospital to investigate whether combining two endovascular catheter-based procedures will improve the long-term outcome in the treatment of atrial fibrillation, the most common heart rhythm disorder. Mass General is the first hospital in New England – and only the second in the nation – to pair renal artery sympathetic denervation with pulmonary vein isolation (PVI) for patients with atrial fibrillation and hypertension.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Call the Massachusetts General Hospital Corrigan Minehan Heart Center outpatient access nurse at 866-644-8910